Leukemia & Lymphoma, Volume 48, Issue 7 (2007)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 48, Issue 7 (2007)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Volume 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentary

Article Commentary
What influence has B-cell depletion on viral infections?
Anjum S. Kaka, Cliona M. Rooney & Barbara Savoldo
Pages: 1257-1258
Published online: 01 Jul 2009
CitationforWhat influence has B-cell depletion on viral infections? | Full Text | References | PDF (53.2 KB)
  • 75 Views
  • 1 CrossRef citations
  • 0Altmetric
Article Commentary
IL-4 as therapy for non-Hodgkin's lymphoma: Possibilities but major challenges
Peter Martin & John P. Leonard
Pages: 1259-1260
Published online: 01 Jul 2009
CitationforIL-4 as therapy for non-Hodgkin's lymphoma: Possibilities but major challenges | Full Text | References | PDF (53.7 KB)
  • 68 Views
  • 1 CrossRef citations
  • 0Altmetric
Article Commentary
IL-4 in lymphoma: Does the target matter?
Izidore S. Lossos
Pages: 1261-1263
Published online: 01 Jul 2009
First Page PreviewforIL-4 in lymphoma: Does the target matter? | Full Text | References | PDF (58.2 KB)
  • 61 Views
  • 1 CrossRef citations
  • 0Altmetric
Article Commentary
Bendamustine in lymphomas: More to combine?
Francesco Bertoni & Emanuele Zucca
Pages: 1264-1266
Published online: 01 Jul 2009
First Page PreviewforBendamustine in lymphomas: More to combine? | Full Text | References | PDF (131.5 KB)
  • 48 Views
  • 2 CrossRef citations
  • 0Altmetric
Article Commentary
Differentiation impairment and the evolution of MDS
Nadim Mahmud MD, PhD & Yogen Saunthararajah
Pages: 1267-1268
Published online: 01 Jul 2009
CitationforDifferentiation impairment and the evolution of MDS | Full Text | References | PDF (49 KB)
  • 37 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review Article
Poor prognosis in acute lymphoblastic leukemia may relate to promoter hypermethylation of cancer-related genes
Jose Roman-Gomez, Antonio Jimenez-Velasco, Manuel Barrios, Felipe Prosper, Anabel Heiniger, Antonio Torres & Xabier Agirre
Pages: 1269-1282
Published online: 01 Jul 2009
AbstractforPoor prognosis in acute lymphoblastic leukemia may relate to promoter hypermethylation of cancer-related genes | Full Text | References | PDF (848.6 KB)
  • 234 Views
  • 44 CrossRef citations
  • 0Altmetric
Review Article
Multipotent mesenchymal stromal cells and immune tolerance
Danièle Noël, Farida Djouad, Carine Bouffi, Dominique Mrugala & Christian Jorgensen
Pages: 1283-1289
Published online: 01 Jul 2009
AbstractforMultipotent mesenchymal stromal cells and immune tolerance | Full Text | References | PDF (345.8 KB)
  • 506 Views
  • 103 CrossRef citations
  • 0Altmetric

Original

Article
Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: A phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51
David M. Kurtz, Loren K. Tschetter, Jacob B. Allred, Susan M. Geyer, Paul J. Kurtin, Wesley D. Putnam, Kendrith M. Rowland Jr, Martin Wiesenfeld, Gamini S. Soori, Richard C. Tenglin, Albert M. Bernath & Thomas E. Witzig
Pages: 1290-1298
Published online: 01 Jul 2009
AbstractforSubcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: A phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51 | Full Text | References | PDF (461.2 KB)
  • 225 Views
  • 16 CrossRef citations
  • 0Altmetric
Article
High anti-lymphoma activity of bendamustine/mitoxantrone/rituximab in rituximab pretreated relapsed or refractory indolent lymphomas and mantle cell lymphomas. A multicenter phase II study of the German Low Grade Lymphoma Study Group (GLSG)
Rudolf Weide, Georg Hess, Hubert Köppler, Jochen Heymanns, Jörg Thomalla, Ali Aldaoud, Christoph Losem, Stefan Schmitz, Ursula Haak, Christoph Huber, Michael Unterhalt, Wolfgang Hiddemann & Martin Dreyling
Pages: 1299-1306
Published online: 01 Jul 2009
AbstractforHigh anti-lymphoma activity of bendamustine/mitoxantrone/rituximab in rituximab pretreated relapsed or refractory indolent lymphomas and mantle cell lymphomas. A multicenter phase II study of the German Low Grade Lymphoma Study Group (GLSG) | Full Text | References | PDF (290.3 KB)
  • 549 Views
  • 79 CrossRef citations
  • 0Altmetric
Article
Rituximab-related viral infections in lymphoma patients
Sercan Aksoy, Hakan Harputluoglu, Saadettin Kilickap, Didem Sener Dede, Omer Dizdar, Kadri Altundag & Ibrahim Barista
Pages: 1307-1312
Published online: 01 Jul 2009
AbstractforRituximab-related viral infections in lymphoma patients | Full Text | References | PDF (84.6 KB)
  • 1072 Views
  • 199 CrossRef citations
  • 0Altmetric
Article
Single agent bortezomib in the treatment of relapsed and refractory Hodgkin lymphoma: Cancer and leukemia Group B protocol 50206
Kristie A. Blum, Jeffrey L. Johnson, Donna Niedzwiecki, George P. Canellos, Bruce D. Cheson & Nancy L. Bartlett
Pages: 1313-1319
Published online: 01 Jul 2009
AbstractforSingle agent bortezomib in the treatment of relapsed and refractory Hodgkin lymphoma: Cancer and leukemia Group B protocol 50206 | Full Text | References | PDF (182.1 KB)
  • 169 Views
  • 58 CrossRef citations
  • 0Altmetric
Article
Microsatellite instability indicative of defects in the major mismatch repair genes is rare in patients with B-cell chronic lymphocytic leukemia: Evaluation with disease stage and family history
G. S. Sellick, S. J. Lubbe, E. Matutes, D. Catovsky & R. S. Houlston
Pages: 1320-1322
Published online: 01 Jul 2009
AbstractforMicrosatellite instability indicative of defects in the major mismatch repair genes is rare in patients with B-cell chronic lymphocytic leukemia: Evaluation with disease stage and family history | Full Text | References | PDF (63.1 KB)
  • 74 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Association between Epstein-Barr virus and Hodgkin's lymphoma in Belgium: A pathological and virological study
Mounir Trimèche, Christophe Bonnet, Sadok Korbi, Jacques Boniver & Laurence de Leval
Pages: 1323-1331
Published online: 01 Jul 2009
AbstractforAssociation between Epstein-Barr virus and Hodgkin's lymphoma in Belgium: A pathological and virological study | Full Text | References | PDF (400 KB)
  • 94 Views
  • 12 CrossRef citations
  • 0Altmetric
Article
Effectiveness of second line salvage chemotherapy with ifosfamide, carboplatin, and etoposide in patients with relapsed diffuse large B-cell lymphoma not responding to cis-platinum, cytosine arabinoside, and dexamethasone
Lijo Simpson, Stephen M. Ansell, Joseph P. Colgan, Thomas M. Habermann, David J. Inwards, Kay M. Ristow, Patrick B. Johnston, Svetomir N. Markovic, Ivana N. Micallef, Luis F. Porrata & Thomas E. Witzig MD
Pages: 1332-1337
Published online: 01 Jul 2009
AbstractforEffectiveness of second line salvage chemotherapy with ifosfamide, carboplatin, and etoposide in patients with relapsed diffuse large B-cell lymphoma not responding to cis-platinum, cytosine arabinoside, and dexamethasone | Full Text | References | PDF (150.4 KB)
  • 327 Views
  • 15 CrossRef citations
  • 0Altmetric
Article
Application of BIOMED-2 clonality assays to formalin-fixed paraffin embedded follicular lymphoma specimens: Superior performance of the IGK assays compared to IGH for suboptimal specimens
Anna Margrét Halldórsdóttir, Barbara A. Zehnbauer & W. Richard Burack
Pages: 1338-1343
Published online: 01 Jul 2009
AbstractforApplication of BIOMED-2 clonality assays to formalin-fixed paraffin embedded follicular lymphoma specimens: Superior performance of the IGK assays compared to IGH for suboptimal specimens | Full Text | References | PDF (83.7 KB)
  • 262 Views
  • 33 CrossRef citations
  • 0Altmetric
Article
Characterization of genetic changes in MCL by interphase FISH on tissue sections
Birgitta Sander, Ann Wallblom, Andrea Ekroth, Anna Porwit & Eva Kimby
Pages: 1344-1352
Published online: 01 Jul 2009
AbstractforCharacterization of genetic changes in MCL by interphase FISH on tissue sections | Full Text | References | PDF (773.6 KB)
  • 93 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Differentiation and hematopoietic-support of clonal cells in myelodysplastic syndromes
Xiao Li, LingYun Wu, Shaoxu Ying, Chunkang Chang, Qi He & Quan Pu
Pages: 1353-1371
Published online: 01 Jul 2009
AbstractforDifferentiation and hematopoietic-support of clonal cells in myelodysplastic syndromes | Full Text | References | PDF (1 MB)
  • 55 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
The clinical, haematological and morphological profile of patients with myelodysplastic syndromes: A single institution experience from Turkey
Fatih Demirkan, Inci Alacacioglu, Ozden Piskin, Hayri G. Ozsan, Baris Akinci, Ali M. Ozcan, Tugba Yavuzsen, Erdinc Yuksel & Bulent Undar
Pages: 1372-1378
Published online: 01 Jul 2009
AbstractforThe clinical, haematological and morphological profile of patients with myelodysplastic syndromes: A single institution experience from Turkey | Full Text | References | PDF (627.3 KB)
  • 105 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
The tyrosine kinase inhibitor AMN107 (Nilotinib) exhibits off-target effects in lymphoblastic cell lines
Kai Uwe Chow, Daniel Nowak, Bettina Trepohl, Simone Hochmuth, Bernd Schneider, Dieter Hoelzer, Paris S. Mitrou, Lothar Bergmann, Oliver Gerhard Ottmann & Simone Boehrer
Pages: 1379-1388
Published online: 01 Jul 2009
AbstractforThe tyrosine kinase inhibitor AMN107 (Nilotinib) exhibits off-target effects in lymphoblastic cell lines | Full Text | References | PDF (1.2 MB)
  • 206 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
The expression of the Peripheral Cannabinoid receptor on cells of the immune system and Non-Hodgkin's lymphomas
Nazik Rayman, King H. Lam, Joost Van Leeuwen, Andries H. Mulder, Leo M. Budel, Bob Löwenberg, Pieter Sonneveld & Ruud Delwel
Pages: 1389-1399
Published online: 01 Jul 2009
AbstractforThe expression of the Peripheral Cannabinoid receptor on cells of the immune system and Non-Hodgkin's lymphomas | Full Text | References | PDF (3.1 MB)
  • 162 Views
  • 13 CrossRef citations
  • 0Altmetric
Article
Homoharringtonine induces apoptosis and growth arrest in human myeloma cells
Yin-Jun Lou, Wen-Bin Qian & Jie Jin
Pages: 1400-1406
Published online: 01 Jul 2009
AbstractforHomoharringtonine induces apoptosis and growth arrest in human myeloma cells | Full Text | References | PDF (1 MB)
  • 145 Views
  • 25 CrossRef citations
  • 0Altmetric
Article
Case 36: A difficult diagnosis in a patient with fever and progressive multi-organ failure
Ian H. Gabriel, Nick Chong, Alexandra Rice, Rupert Negus & Barbara J. Bain
Pages: 1407-1409
Published online: 01 Jul 2009
AbstractforCase 36: A difficult diagnosis in a patient with fever and progressive multi-organ failure | Full Text | References | PDF (801.2 KB)
  • 50 Views
  • 3 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter
Hepatosplenic T-cell lymphoma in a patient with Crohn's disease who received infliximab therapy
Amer Zeidan, Ronald Sham, Joel Shapiro, Anthony Baratta & Peter Kouides
Pages: 1410-1413
Published online: 01 Jul 2009
First Page PreviewforHepatosplenic T-cell lymphoma in a patient with Crohn's disease who received infliximab therapy | Full Text | References | PDF (208.2 KB)
  • 177 Views
  • 41 CrossRef citations
  • 0Altmetric
Letter
Very late relapse of B cell lymphoma masquerading as blastic transformation of chronic myeloid leukemia
Wing Y. Au, Kai Y. Wong, Thomas S. Wan, Jason C. So, Gopesh Srivastava & Simon H. M. Wong
Pages: 1414-1416
Published online: 01 Jul 2009
First Page PreviewforVery late relapse of B cell lymphoma masquerading as blastic transformation of chronic myeloid leukemia | Full Text | References | PDF (469.9 KB)
  • 42 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Hypereosinophilia in biphenotypic (B-cell/T-cell) acute lymphoblastic leukemia
Sook Young Bae, Soo-Young Yoon, Ji Hoon Huh, Hwa Jung Sung & In Keun Choi
Pages: 1417-1419
Published online: 01 Jul 2009
First Page PreviewforHypereosinophilia in biphenotypic (B-cell/T-cell) acute lymphoblastic leukemia | Full Text | References | PDF (164.4 KB)
  • 92 Views
  • 8 CrossRef citations
  • 0Altmetric
Letter
IgG multiple myeloma presented with ulcerative pyoderma gangrenosum
Evgenia Verrou, Charalambos Kartsios MD, Anastassia Banti, Dimitra Mihou, Vassiliki Kaloutsi, Anna Lazaridou & Konstantinos Zervas
Pages: 1420-1422
Published online: 01 Jul 2009
First Page PreviewforIgG multiple myeloma presented with ulcerative pyoderma gangrenosum | Full Text | References | PDF (135.9 KB)
  • 142 Views
  • 8 CrossRef citations
  • 0Altmetric
Letter
Effectiveness of lenalidomide (Revlimid) for the treatment of plasma cell leukemia
Don M. Benson Jr MD PhD & Megan K. Smith
Pages: 1423-1425
Published online: 01 Jul 2009
First Page PreviewforEffectiveness of lenalidomide (Revlimid) for the treatment of plasma cell leukemia | Full Text | References | PDF (162 KB)
  • 266 Views
  • 24 CrossRef citations
  • 0Altmetric
Letter
Efficacy of bortezomib in combination chemotherapy on secondary plasma cell leukemia
Ridvan Ali, Meral Beksac, Fahir Ozkalemkas, Vildan Ozkocaman, Atilla Ozkan, Tulay Ozcelik & Ahmet Tunali
Pages: 1426-1428
Published online: 01 Jul 2009
First Page PreviewforEfficacy of bortezomib in combination chemotherapy on secondary plasma cell leukemia | Full Text | References | PDF (60.9 KB)
  • 113 Views
  • 5 CrossRef citations
  • 0Altmetric
Letter
Salvage immuno-chemotherapy with a combination of rituximab, high-dose cytarabine, mitoxantrone and dexamethasone for patients with primary CNS lymphoma: A preliminary study
Ryuya Yamanaka MD, PhD, Junpei Homma, Masakazu Sano, Naoto Tsuchiya, Naoki Yajima, Hideaki Takahashi, Yoshikatsu Shinbo, Akira Hasegawa, Takashi Saitoh & Ryuichi Tanaka
Pages: 1429-1433
Published online: 01 Jul 2009
First Page PreviewforSalvage immuno-chemotherapy with a combination of rituximab, high-dose cytarabine, mitoxantrone and dexamethasone for patients with primary CNS lymphoma: A preliminary study | Full Text | References | PDF (189.1 KB)
  • 98 Views
  • 5 CrossRef citations
  • 0Altmetric
Letter
Bilateral proptosis as the initial presentation of systemic nodular lymphocyte predominant Hodgkin lymphoma
Ayla Gokmen Akoz MD, Simten Dagdas, Hulya Soysal, Gulsum Ozet & Huseyin Ustun
Pages: 1434-1436
Published online: 01 Jul 2009
First Page PreviewforBilateral proptosis as the initial presentation of systemic nodular lymphocyte predominant Hodgkin lymphoma | Full Text | References | PDF (932.1 KB)
  • 42 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Primary intracranial dural B cell small lymphocytic lymphoma
Annamaria Giordano, Tommasina Perrone, Attilio Guarini, Pasqualino Ciappetta, Giuseppe Rubini, Rosalia Ricco, Michele Palma, Giorgina Specchia & Vincenzo Liso
Pages: 1437-1443
Published online: 01 Jul 2009
First Page PreviewforPrimary intracranial dural B cell small lymphocytic lymphoma | Full Text | References | PDF (1.2 MB)
  • 119 Views
  • 8 CrossRef citations
  • 0Altmetric
Letter
KSHV- and EBV-associated germinotropic lymphoproliferative disorder: A rare lymphoproliferative disease of HIV patient with plasmablastic morphology, indolent course and favourable response to therapy
Antonio D'Antonio, Amedeo Boscaino, Maria Addesso, Miguel Angel Piris & Oscar Nappi
Pages: 1444-1447
Published online: 01 Jul 2009
First Page PreviewforKSHV- and EBV-associated germinotropic lymphoproliferative disorder: A rare lymphoproliferative disease of HIV patient with plasmablastic morphology, indolent course and favourable response to therapy | Full Text | References | PDF (1.5 MB)
  • 254 Views
  • 23 CrossRef citations
  • 0Altmetric
Letter
Graft-versus-lymphoma effect in progressive hepatosplenic gamma/delta T-cell lymphoma
Simon He, Andrew Roberts, David Ritchie & Andrew Grigg
Pages: 1448-1450
Published online: 01 Jul 2009
First Page PreviewforGraft-versus-lymphoma effect in progressive hepatosplenic gamma/delta T-cell lymphoma | Full Text | References | PDF (358.5 KB)
  • 105 Views
  • 13 CrossRef citations
  • 0Altmetric
Letter
Two cases of primary malignant NK/T-cell lymphoma in the small intestine following an aggressive clinical course: Morphological, immunohistochemical, and molecular analysis
Pierre Moubayed MD, Frank Leithäuser, Thomas Binder, Michael Uppenkamp & Alfred C. Feller
Pages: 1451-1455
Published online: 01 Jul 2009
First Page PreviewforTwo cases of primary malignant NK/T-cell lymphoma in the small intestine following an aggressive clinical course: Morphological, immunohistochemical, and molecular analysis | Full Text | References | PDF (692.2 KB)
  • 46 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Autoimmune paraneoplastic cerebellar degeneration secondary to a composite lymphoma
Aurangzeb RazZak, Michael Shields & David Allsup
Pages: 1456-1458
Published online: 01 Jul 2009
First Page PreviewforAutoimmune paraneoplastic cerebellar degeneration secondary to a composite lymphoma | Full Text | References | PDF (358.5 KB)
  • 58 Views
  • 2 CrossRef citations
  • 0Altmetric

Erratum

Correction
Valproic acid monotherapy leads to CR in a patient with refractory diffuse large B cell lymphoma
Jasmine Zain, Arnold Rotter, Lawrence Weiss, Stephen Forman & Mark H. Kirschbaum
Page: 1459
Published online: 01 Jul 2009
CitationforValproic acid monotherapy leads to CR in a patient with refractory diffuse large B cell lymphoma | Full Text | PDF (40.9 KB)
  • 191 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Emerging drug profile: JAK inhibitors
Alexander Coltoff et al.
Published online: 13 May 2024
A de novo germline RUNX1 variant preceding development of concurrent T-lymphoblastic leukemia and myelodysplastic syndrome
Cassandra P. Wang et al.
Letter to the Editor | Published online: 11 May 2024
Advances in the management of higher-risk myelodysplastic syndromes: future prospects
Georgina Gener-Ricos et al.
Review Article | Published online: 7 May 2024
Safety and tolerability of AMG 330 in adults with relapsed/refractory AML: a phase 1a dose-escalation study
Farhad Ravandi et al.
Article | Published online: 7 May 2024
View all latest articles